IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 47,400
-200 (-0.42%)
At close: Mar 20, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 711.57 billion as of March 20, 2026.
Market Cap
711.57B
Enterprise Value
691.35B
Revenue
1.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
47,400.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 711.57B, an increase of 44.53%. That is a compound annual growth rate of 56.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 711.57B | -17.36% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 1.51T |
| JS Link | 1.37T |
| Inventage Lab | 1.06T |
| HansBiomed | 755.85B |
| Curocell | 722.22B |
| Y-Biologics | 525.92B |
| S.Biomedics | 411.81B |
| curacle co.,ltd. | 392.63B |